Precigen Inc has a consensus price target of $7.5, established from looking at the 13 latest analyst ratings. The last 3 analyst ratings were released from JP Morgan, JMP Securities, and HC Wainwright & Co. on March 22, 2024, March 20, 2024, and March 20, 2024. With an average price target of $6.67 between JP Morgan, JMP Securities, and HC Wainwright & Co., there's an implied 397.51% upside for Precigen Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/22/2024 | PGEN | Buy Now | Precigen | $1.34 | — | JP Morgan | Brian Cheng | — | Downgrade | Neutral → Underweight | Get Alert |
03/20/2024 | PGEN | Buy Now | Precigen | $1.34 | 944.78% | JMP Securities | Jason Butler | → $14 | Reiterates | Market Outperform → Market Outperform | Get Alert |
03/20/2024 | PGEN | Buy Now | Precigen | $1.34 | 347.76% | HC Wainwright & Co. | Swayampakula Ramakanth | → $6 | Reiterates | Buy → Buy | Get Alert |
08/10/2023 | PGEN | Buy Now | Precigen | $1.34 | 347.76% | HC Wainwright & Co. | Swayampakula Ramakanth | → $6 | Reiterates | Buy → Buy | Get Alert |
06/05/2023 | PGEN | Buy Now | Precigen | $1.34 | 944.78% | JMP Securities | Jason Butler | → $14 | Reiterates | → Market Outperform | Get Alert |
05/23/2023 | PGEN | Buy Now | Precigen | $1.34 | — | JP Morgan | Brian Cheng | — | Initiates | → Neutral | Get Alert |
05/11/2023 | PGEN | Buy Now | Precigen | $1.34 | 944.78% | JMP Securities | Jason Butler | → $14 | Reiterates | Market Outperform → Market Outperform | Get Alert |
03/07/2023 | PGEN | Buy Now | Precigen | $1.34 | 944.78% | JMP Securities | Jason Butler | → $14 | Reiterates | → Market Outperform | Get Alert |
03/07/2023 | PGEN | Buy Now | Precigen | $1.34 | 347.76% | HC Wainwright & Co. | Swayampakula Ramakanth | → $6 | Reiterates | → Buy | Get Alert |
01/30/2023 | PGEN | Buy Now | Precigen | $1.34 | 646.27% | Cantor Fitzgerald | Jennifer Kim | $7 → $10 | Maintains | Overweight | Get Alert |
11/18/2022 | PGEN | Buy Now | Precigen | $1.34 | 422.39% | Cantor Fitzgerald | Jennifer Kim | → $7 | Initiates | → Overweight | Get Alert |
11/10/2022 | PGEN | Buy Now | Precigen | $1.34 | 944.78% | JMP Securities | Jason Butler | $13 → $14 | Maintains | Market Outperform | Get Alert |
08/09/2022 | PGEN | Buy Now | Precigen | $1.34 | 347.76% | HC Wainwright & Co. | Swayampakula Ramakanth | $10 → $6 | Maintains | Buy | Get Alert |
The latest price target for Precigen (NASDAQ: PGEN) was reported by JP Morgan on March 22, 2024. The analyst firm set a price target for $0.00 expecting PGEN to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for Precigen (NASDAQ: PGEN) was provided by JP Morgan, and Precigen downgraded their underweight rating.
There is no last upgrade for Precigen.
The last downgrade for Precigen Inc happened on March 22, 2024 when JP Morgan changed their price target from N/A to N/A for Precigen Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Precigen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Precigen was filed on March 22, 2024 so you should expect the next rating to be made available sometime around March 22, 2025.
While ratings are subjective and will change, the latest Precigen (PGEN) rating was a downgraded with a price target of $0.00 to $0.00. The current price Precigen (PGEN) is trading at is $1.34, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.